Pioneering therapies that restore mitochondrial bioenergetics to target degenerative and metabolic conditions via enzyme activation and DNA modulation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Pretzel Therapeutics is a biotech company developing first‑in‑class small molecule treatments that restore mitochondrial function by activating enzymes critical to mitochondrial DNA maintenance. It employs a proprietary energetics‑focused platform to modulate bioenergetic pathways across a wide spectrum of neurological, metabolic, muscle‑wasting, and rare diseases, aiming to improve cellular survival and function by correcting energy regulation.
Pretzel Therapeutics Funding
Sign up to gain insights into Pretzel Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Aug 09, 2024 | 59M | ||
| Series A | Sep 12, 2022 | 73M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Pretzel Therapeutics Management Team
Investors
Angelini Ventures
ARCH Venture Partners
Cambridge Enterprise
Cambridge Innovation Capital plc (CIC)
Eir Ventures
Google Ventures
GU Ventures
HealthCap Partners LLC
Invus Group
Karolinska Institutet Holding
Mito Funds
Mubadala Capital
Pretzel Therapeutics Valuations & Financials
View real-time NPM data on Pretzel Therapeutics stock including daily Pretzel Therapeutics stock price estimates, valuation history, and historical share price information. Access Pretzel Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Pretzel Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Pretzel Therapeutics? Get in touch to learn more.
Similar Companies
like Pretzel Therapeutics
Iris Telehealth
Healthcare & Life Sciences
Telepsychiatry services for community mental health systems.
Trusted
Healthcare & Life Sciences
Digital employment platform built by nurses for nurses.
Nutcracker Therapeutics
Healthcare & Life Sciences
Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.
Rightway
Healthcare & Life Sciences
Guides members to optimal care and medications with personalized navigation and transparent pharmacy benefit solutions.
Brightseed
Healthcare & Life Sciences
Discovers plant-based bioactive compounds to enhance health, providing sustainable solutions for food, beverage, and wellness.
Tempus Labs
Healthcare & Life Sciences
Utilizes AI-driven data integration to deliver personalized medical insights.
FAQ
We have answers
Pretzel Therapeutics stock does not trade on public stock exchanges. Pretzel Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Pretzel Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Pretzel Therapeutics Stock does not trade on public stock exchanges. In order to sell Pretzel Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Pretzel Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Pretzel Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Pretzel Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Pretzel Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Pretzel Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Pretzel Therapeutics is a private company and has not had an IPO. There is currently no Pretzel Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Pretzel Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
